Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies. Click here to find out why I ...
By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.
“As we entered 2024, the Company had three primary goals in our quest to ensure we are ready for the successful commercial launch of LIBERTY in 2025: 1) complete FDA 510(k) submission ...
Chimerix submitted a new drug application to the FDA seeking accelerated approval for dordaviprone to treat patients with ...
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...